All 13 sessions from the 2023 National Clinicians Conference on Medical Aid in Dying are now available online. For free viewing of the sessions from the please click here.

The 2023 conference sessions are also available for online continuing education credits for nurses, social workers, and physicians — at $10/unit-session for nurses and social workers, $15/unit-session for physicians. Please use this link to view the sessions and receive continuing education credits.

Sessions from the 2020 National Clinicians Conference on Medical Aid in Dying are no longer available for continuing education credits, but you are welcome to view them for your interest. (They are at the bottom of this web page.)

Academy education materials (below), remain free of charge for viewing and for continuing education credits:

California’s SB380: A clinical perspective
(1 unit)

Aid-in-Dying Training for End-of-Life Doulas

NOTE: CME/CE credits are not provided with these doula training videos, but all are welcome (and encouraged) to view them.

Rectal Administration of Aid-in-Dying Medications
(0.25 CME/CE Units)

Nursing Best Practices for Medical Aid in Dying
Part 1: Introduction, and Becoming Eligible for Medical Aid in Dying
(0.5 CME/CE units)
Part 2: Monitoring and Preparing Patients for Medical Aid in Dying.
(0.5 CME/CE units)
Part 3: The Aid-in-Dying Day
(0.5 CME/CE units)

Aid in Dying at the Bedside, an enactment of an attended death
(0.25 CME/CE units)

Dancing with Prognostic Dilemmas
(1 CME/CE unit).

Coronavirus and Aid in Dying
(O.25 CME/CE units)

Religion-based Providers and Medical Aid in Dying
(0.5 CME/CE units)

Sessions of the 2020 National Clinicians Conference on Medical Aid in Dying, Berkeley, California: These sessions are no longer available for continuing education credits, but you are welcome to view them for your interest and education.

Introduction, and Basics and State Differences

Hospices and Aid in Dying

The Pharmacology and Physiology of Medical Aid in Dying

Care at the Bedside: Monitoring and Guiding Eligible Patients

Capacity and Prognosis

Evaluation and Management of Patients at High Risk of Prolonged Death

Race Matters: Ethnic, Cultural and Spiritual Considerations in Aid in Dying

Bereavement, and Managing Social Complexity in Patients and Families

Attending Aid-in-Dying Deaths

Aid in Dying Practice Pragmatics

Plans Change: When Aid in Dying Cannot be Implemented

How to Talk About Aid in Dying

Pharmacists: Compounding, Teaching, and Informing

Accreditation:

Physician CME Accreditation (where applicable, as noted above): This Enduring Material activity has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Nursing Accreditation: American Clinicians Academy on Medical Aid in Dying, Thalia DeWolf, RN, CHPN, Director of Nurse Education. Provider approved by the California Board of Registered Nursing, Provider #17745.

Social Worker Accreditation: These programs are approved by the National Association of Social Workers. Approval # 886888130-5659

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in these activities are not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in these activities should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

These educational activities may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. The opinions expressed in the educational activities are those of the faculty and do not necessarily represent the views of the Academy. Please refer to the official prescribing information for each product for discussions of approved indications, contraindications, and warnings.

Disclosure of Conflicts of Interest

The Academy requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest they may have as related to the content of this activity. The Academy is committed to providing its learners with high-quality activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest or a commercial interest.